Cargando…
Comorbidities and medications of patients with chronic hepatitis C under specialist care in the UK
Designing services with the capacity and expertise to meet the needs of the chronic hepatitis C (CHC) population in the era of direct acting antivirals (DAAs), and widening access to such treatments, requires detailed understanding of the characteristics and healthcare needs of the existing patient...
Autores principales: | Hudson, Benjamin, Walker, Alex J., Irving, William L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656818/ https://www.ncbi.nlm.nih.gov/pubmed/28480974 http://dx.doi.org/10.1002/jmv.24848 |
Ejemplares similares
-
Knowledge, Attitudes and Practice of Iranian Medical Specialists regarding Hepatitis B and C
por: Kabir, Ali, et al.
Publicado: (2010) -
Patient Characteristics and Comorbidities in Patients Attending Specialist Foot and Ankle Outpatient Clinics in the UK: A Report of 2000 Patients
por: Houchen-Wolloff, Linzy, et al.
Publicado: (2020) -
Medical comorbidity and projected survival in patients admitted to a specialist addictions in-patient unit
por: Mogford, Daniel V., et al.
Publicado: (2016) -
Comorbidities and Prescribed Medications in Korean Patients with Chronic Hepatitis C: A Nationwide, Population-Based Study
por: Chung, Jung Wha, et al.
Publicado: (2021) -
Comorbidities and co-medications in populations with and without chronic hepatitis C virus infection in Japan between 2015 and 2016
por: Ruzicka, Daniel J., et al.
Publicado: (2018)